ALT - Altimmune, Inc.

2.6
-0.030   -1.154%

Share volume: 5,638,491
Last Updated: 04-30-2026
Pharmaceutical Products/Pharmaceutical Preparations: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$2.63
-0.03
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-09-2024 08-08-2024 11-12-2024 02-27-2025 05-13-2025 08-12-2025 11-06-2025 03-06-2026
Total revenue 5.000 K 5.000 K 5.000 K 5.000 K 5.000 K 5.000 K 5.000 K 26.000 K
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 5.000 K 5.000 K 5.000 K 5.000 K 5.000 K 5.000 K 5.000 K 26.000 K
    0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 420.00%  
Operating expenses 26.799 M 26.750 M 24.772 M 24.871 M 21.820 M 22.927 M 20.864 M 28.919 M
Selling general and admin 5.312 M 5.595 M 4.969 M 5.090 M 5.993 M 5.691 M 5.904 M 10.510 M
Research and development 21.487 M 21.155 M 19.803 M 19.781 M 15.827 M 17.236 M 14.960 M 18.409 M
Total expenses 26.799 M 26.750 M 24.772 M 24.871 M 21.820 M 22.927 M 20.864 M 28.919 M
    -0.18% -7.39% 0.40% -12.27% 5.07% -9.00% 38.61%  
Operating income -26.794 M -26.745 M -24.767 M -24.866 M -21.815 M -22.922 M -20.859 M -28.893 M
Ebit -26.806 M -26.821 M -24.749 M -24.748 M -21.800 M -23.014 M -20.945 M -28.920 M
Pretax income 0.000 0.000 -22.845 M -72.214 M -20.256 M -22.146 M -19.014 M -27.358 M
    nan% inf% 216.10% -71.95% 9.33% -14.14% 43.88%  
Income tax 0.000 0.000 0.000 0.000 -681.000 K 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -24.394 M -24.640 M -22.845 M -23.180 M -19.575 M -22.146 M -19.014 M -27.358 M
    -1.01% 7.28% -1.47% 15.55% -13.13% 14.14% -43.88%